107 related articles for article (PubMed ID: 21727905)
1. Blood lipid levels and prostate cancer risk; a cohort study.
Kok DE; van Roermund JG; Aben KK; den Heijer M; Swinkels DW; Kampman E; Kiemeney LA
Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):340-5. PubMed ID: 21727905
[TBL] [Abstract][Full Text] [Related]
2. Plasma total, LDL, and HDL cholesterol and risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Jacobs EJ; Stevens VL; Newton CC; Gapstur SM
Cancer Causes Control; 2012 Aug; 23(8):1289-96. PubMed ID: 22692409
[TBL] [Abstract][Full Text] [Related]
3. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
4. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
[TBL] [Abstract][Full Text] [Related]
5. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
6. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
Hammarsten J; Högstedt B
Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
[TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma lipids and all-cause mortality in nondemented elderly.
Schupf N; Costa R; Luchsinger J; Tang MX; Lee JH; Mayeux R
J Am Geriatr Soc; 2005 Feb; 53(2):219-26. PubMed ID: 15673344
[TBL] [Abstract][Full Text] [Related]
8. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
9. Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.
Rodriguez C; McCullough ML; Mondul AM; Jacobs EJ; Fakhrabadi-Shokoohi D; Giovannucci EL; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):597-603. PubMed ID: 12869397
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
[TBL] [Abstract][Full Text] [Related]
11. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
[TBL] [Abstract][Full Text] [Related]
12. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
13. Association of vasectomy and prostate cancer among men in a Maryland cohort.
Rohrmann S; Paltoo DN; Platz EA; Hoffman SC; Comstock GW; Helzlsouer KJ
Cancer Causes Control; 2005 Dec; 16(10):1189-94. PubMed ID: 16215869
[TBL] [Abstract][Full Text] [Related]
14. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort.
Jacobs EJ; Rodriguez C; Bain EB; Wang Y; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2213-7. PubMed ID: 17971518
[TBL] [Abstract][Full Text] [Related]
16. Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study.
Van Hemelrijck M; Walldius G; Jungner I; Hammar N; Garmo H; Binda E; Hayday A; Lambe M; Holmberg L
Cancer Causes Control; 2011 Jul; 22(7):1011-9. PubMed ID: 21562751
[TBL] [Abstract][Full Text] [Related]
17. Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study.
Platz EA; Leitzmann MF; Michaud DS; Willett WC; Giovannucci E
Cancer Res; 2003 Dec; 63(23):8542-8. PubMed ID: 14679023
[TBL] [Abstract][Full Text] [Related]
18. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
19. The influence of statin medications on prostate-specific antigen levels.
Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
[TBL] [Abstract][Full Text] [Related]
20. Association between serum prostate-specific antigen level, liver function tests and lipid profile in healthy men.
Han JH; Chang IH; Ahn SH; Kwon OJ; Bang SH; Choi NY; Park SW; Myung SC; Kim HW
BJU Int; 2008 Nov; 102(9):1097-101. PubMed ID: 18522630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
